The predicament of an electrophysiologist: Ablating the left common pulmonary vein

2020 ◽  
Vol 31 (9) ◽  
pp. 2308-2309
Author(s):  
Erik Wissner
2012 ◽  
Vol 115 (1) ◽  
pp. 27-29
Author(s):  
Robert J. Suriani ◽  
Albert C. DiMeo ◽  
Raphael P. Squitieri

2020 ◽  
Vol 85 (1) ◽  
pp. 81
Author(s):  
Akio Chikata ◽  
Takeshi Kato ◽  
Shuhei Fujita ◽  
Kazuo Usuda ◽  
Masayuki Takamura

2001 ◽  
Vol 22 (3) ◽  
pp. 255-257 ◽  
Author(s):  
T. Suzuki ◽  
M. Sato ◽  
T. Murai ◽  
T. Fukuda

Circulation ◽  
1972 ◽  
Vol 46 (2) ◽  
pp. 368-374 ◽  
Author(s):  
RICHARD E. HAWKER ◽  
JOHN M. CELERMAJER ◽  
DON C. GENGOS ◽  
TIMOTHY B. CARTMILL ◽  
J. DENBY BOWDLER

2008 ◽  
Vol 3 (6) ◽  
pp. 431-434 ◽  
Author(s):  
Pradeep Vaideeswar ◽  
Milind S. Tullu ◽  
Pragati A. Sathe ◽  
Ruchi Nanavati

1982 ◽  
Vol 83 (3) ◽  
pp. 443-448 ◽  
Author(s):  
Siavosh Khonsari ◽  
Peter W. Saunders ◽  
Martin H. Lees ◽  
Albert Starr

2019 ◽  
Vol 42 (7) ◽  
pp. 882-889
Author(s):  
Wei‐Chieh Lee ◽  
Yi‐Wei Lee ◽  
Hsiu‐Yu Fang ◽  
Huang‐Chung Chen ◽  
Yung‐Lung Chen ◽  
...  

2019 ◽  
Vol 40 (Supplement_1) ◽  
Author(s):  
V Gionti ◽  
M C Negro ◽  
M Longobardi ◽  
C Storti

Abstract Background Conflicting results regarding the impact of left common pulmonary (LCPV) vein on clinical outcome of atrial fibrillation (AF) ablation with cryoballoon technology have been reported. In the present study, we sought to investigate the performance of the 28 mm cryoballoon advance (CB-A) on left common pulmonary vein (LCPV) in terms of post procedural outcome. Methods We systematically searched on PubMed and Cochrane library for the articles that compared the recurrence rate of AF after cryoballoon ablation between patients with four separate and distinct pulmonary vein ostia and with LCPV. Results A total of 5 studies with 1052 patients met our predefined inclusion criteria. Recurrence of AF after CB-A ablation was similar in both groups (Log OR 0.45; 95% CI: −0.03, 0.94; I=48%, p=0.08), Fig 1. Figure 1 Conclusion LCPV doesn't affect clinical outcome of AF ablation with cryoballoon technology.


2017 ◽  
Vol 4 (45) ◽  
pp. 33-34
Author(s):  
Michał Orczykowski

Second-generation cryoballoon (CB2) - based pulmonary vein isolation (PVI) has demonstrated encouraging clinical results in the treatment of paroxysmal (PAF) and persistent atrial fibrillation (PersAF). Nevertheless, the acute efficacy, safety, and long-term clinical results of CB2-based PVI in patients with a left common pulmonary vein (LCPV) are still a matter of debate. Commented paper by Heeger ChH, et al. analyzes this issue with some practical conclusions.


Sign in / Sign up

Export Citation Format

Share Document